Morgan Stanley has illustrated robust operating performance since the turn of the year. MS's wealth and investment management segments show non-cyclical growth potential, while investment banking ...

Morgan Stanley reported slightly better than expected Q4 results - and the stock is up as much as 4% in pre-market trading. Although results were solid, net income contracted by about 40% as compared ...

One stock that might be an intriguing choice for investors right now is Morgan Stanley MS. This is because this security in the Financial - Investment Bank space is seeing solid earnings estimate ...

As previously reported, Morgan Stanley upgraded Synchrony (SYF) to Overweight from Underweight with a price target of $82, up from $40. The firm adds EPS upside from late fee rule preparatory actions ...

Morgan Stanley’s results were “surprisingly solid,” one analyst said. A likely rebound in banking activity could provide a foundation for margin normalization, another analyst added. Investors look ...

Morgan Stanley analyst Patrick Wood raised the firm’s price target on GE HealthCare (GEHC) to $80 from $74 and keeps an Equal Weight rating on the ...